Introduction The management of lipid disorders, particularly high cholesterol, remains a cornerstone of cardiovascular disease prevention. Traditional approaches often rely on a “one-size-fits-all” strategy, employing statins and lifestyle modifications for all patients. However, this approach overlooks the significant inter-individual variability in response to treatment and inherent genetic predisposition to dyslipidemia. Says Dr. Zachary Solomon, advances in […]